Visiomed Group S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ALVMG.PA research report →
About the company
Visiomed Group SA is an enterprise specializing in the development and global distribution of electronic medical instruments throughout Europe and internationally. Its extensive product portfolio includes temperature measurement devices, blood pressure cuffs, pulse oxygen sensors, smart blood glucose meters, and networked electrocardiogram machines. Additionally, the company offers various pain management solutions, including electrotherapy devices.
- CEO
- Clement Pacaud
- IPO
- 2011
- Employees
- 94
- HQ
- Paris, FR
Price Chart
- Market Cap
- $52.99M
- P/E
- 38.55
- P/S
- 3.26
- P/B
- 1.94
- EV/EBITDA
- 22.12
- Div Yield
- 0.00%
- Gross Margin
- 47.82%
- Op Margin
- 9.65%
- Net Margin
- 8.14%
- ROE
- 5.40%
- ROIC
- 3.98%
- Revenue
- $13.71M · -5.12%
- Net Income
- $902.00K · 117.09%
- EPS
- $0.00 · 115.00%
- Op Income
- $787.00K
- FCF YoY
- 79.36%
- 52W High
- $0.53
- 52W Low
- $0.16
- 50D MA
- $0.19
- 200D MA
- $0.26
- Beta
- -0.63
- Avg Volume
- 1.03M
Get TickerSpark's AI analysis on ALVMG.PA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our ALVMG.PA coverage
Recent articles, reports, and earnings notes.
No research on ALVMG.PA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ALVMG.PA report →Similar companies
Peers in the same neighborhood.